LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 111

Search options

  1. Article: [No title information]

    Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2023  Volume 19, Issue 841, Page(s) 1639–1640

    Title translation 30 ans d’hypertension et les oubliées de la science.
    MeSH term(s) Humans ; Hypertension
    Language French
    Publishing date 2023-09-13
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2023.19.841.1639
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Mécanismes immuno-inflammatoires de l’HTA : apport à la clinique.

    Jacquemoud, Nicolas / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2023  Volume 19, Issue 841, Page(s) 1656–1659

    Abstract: In both industrialized and developing countries, the prevalence of hypertension is increasing. The classical pathophysiology of this major cardiovascular risk factor has recently been enriched by new concepts involving the inflammation and the immune ... ...

    Title translation Immuno-inflammatory mechanisms of hypertension : contribution to the clinic.
    Abstract In both industrialized and developing countries, the prevalence of hypertension is increasing. The classical pathophysiology of this major cardiovascular risk factor has recently been enriched by new concepts involving the inflammation and the immune system as potential players. Indeed in certain immune-mediated inflammatory diseases such as psoriatic arthritis, rheumatoid polyarthritis or lupus erythematosus, but also degenerative arthritis, periodontitis, arterial hypertension is found more frequently than in the general population, often underdiagnosed and poorly controlled, and the cardiovascular (CV) risk is more important. The aim of this article is to review the state of knowledge on this subject, and to draw out any implications for clinical practice.
    MeSH term(s) Humans ; Ambulatory Care Facilities ; Arthritis ; Hypertension/epidemiology ; Hypertension/etiology ; Inflammation ; Knowledge
    Language French
    Publishing date 2023-09-12
    Publishing country Switzerland
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2023.19.841.1656
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Traitement antihypertenseur : la combinaison gagnante.

    Sandoz, Ella / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2023  Volume 19, Issue 841, Page(s) 1642–1646

    Abstract: Detecting, treating and controlling hypertension remains a primary goal in health policy. New recommendations in the management of hypertension were published in 2023 to withhold its global pandemic. The first step is to initiate dual antihypertensive ... ...

    Title translation Antihypertensive treatment: the winning combination.
    Abstract Detecting, treating and controlling hypertension remains a primary goal in health policy. New recommendations in the management of hypertension were published in 2023 to withhold its global pandemic. The first step is to initiate dual antihypertensive therapy in most of the cases by combining 2 molecules from different classes in a single tablet. Subsequent steps involve ensuring blood pressure control and, if indicated, combining other drug classes, again as a single pill combination (SPC). These polypills make it possible to reduce blood pressure more effectively, to offer earlier cardioprotection and to increase patient's compliance while simplifying their treatment and eliminating adverse effects. In this article, we will focus on the combination of antihypertensive classes as a revolutionary paradigm.
    MeSH term(s) Humans ; Antihypertensive Agents/therapeutic use ; Hypertension/drug therapy ; Blood Pressure ; Drug-Related Side Effects and Adverse Reactions ; Health Policy
    Chemical Substances Antihypertensive Agents
    Language French
    Publishing date 2023-09-13
    Publishing country Switzerland
    Document type English Abstract ; Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2023.19.841.1642
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: L’hypertension artérielle a-t-elle un genre?

    Huegli, Sophie / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2022  Volume 18, Issue 795, Page(s) 1689–1692

    Abstract: Women are less frequently affected by arterial hypertension than men during their reproductive life, but their risk catches up and exceeds men's after the menopause. There is a knowledge gap about the specificity of arterial hypertension in women, due to ...

    Title translation Does arterial hypertension have a gender?
    Abstract Women are less frequently affected by arterial hypertension than men during their reproductive life, but their risk catches up and exceeds men's after the menopause. There is a knowledge gap about the specificity of arterial hypertension in women, due to an under inclusion of women in clinical trials. Hypertensive disorders of pregnancy are a recognized ulterior cardiovascular risk factor, and obstetrical history must be part of the evaluation of hypertensive women. In certain cases, we propose to lower the doses of antihypertensive medications in women, due to increased efficiency and increased risk of secondary effects, most notably for thiazide diuretics and calcium channel blockers.
    MeSH term(s) Antihypertensive Agents/therapeutic use ; Calcium Channel Blockers/therapeutic use ; Female ; Humans ; Hypertension/diagnosis ; Hypertension/drug therapy ; Hypertension/epidemiology ; Male ; Pregnancy
    Chemical Substances Antihypertensive Agents ; Calcium Channel Blockers
    Language French
    Publishing date 2022-09-14
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2022.18.795.1689
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Hypertension artérielle : ce qui a changé en 2022.

    Wuerzner, Grégoire / Ponte, Belén / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2023  Volume 19, Issue 812, Page(s) 221–224

    Abstract: Our article summarizing the most important studies of the past year emphasizes the difficulty of controlling blood pressure (BP) in hypertensive patients. In addition, it discusses factors such as temperature and sodium that may influence BP, proposes ... ...

    Title translation Hypertension: what's new in 2022.
    Abstract Our article summarizing the most important studies of the past year emphasizes the difficulty of controlling blood pressure (BP) in hypertensive patients. In addition, it discusses factors such as temperature and sodium that may influence BP, proposes new targets in pregnant hypertensive patients, and challenges the usefulness of taking an antihypertensive drug nightly. Finally, a strategy targeting endothelin blockade in resistant hypertension is presented.
    MeSH term(s) Pregnancy ; Female ; Humans ; Hypertension/drug therapy ; Antihypertensive Agents/therapeutic use ; Antihypertensive Agents/pharmacology ; Blood Pressure ; Sodium
    Chemical Substances Antihypertensive Agents ; Sodium (9NEZ333N27)
    Language French
    Publishing date 2023-02-01
    Publishing country Switzerland
    Document type English Abstract ; Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2023.19.812.221
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Hypertension artérielle : ce qui a changé en 2023.

    Wuerzner, Gregoire / Ponte, Belen / Pechere-Bertschi, Antoinette

    Revue medicale suisse

    2024  Volume 20, Issue 859, Page(s) 252–254

    Abstract: Highlights for 2023 include the confirmation of hypertension as a cardiovascular risk factor and the standard procedure for measuring blood pressure. Transdermal oestrogens do not appear to be associated with an increased risk of hypertension unlike ... ...

    Title translation Hypertension: what's new in 2023.
    Abstract Highlights for 2023 include the confirmation of hypertension as a cardiovascular risk factor and the standard procedure for measuring blood pressure. Transdermal oestrogens do not appear to be associated with an increased risk of hypertension unlike oestrogen given orally. The usefulness of blood pressure measured in hospital in elderly patients and the risks of intensive treatment are reviewed. A new study suggests that we are not all equal when it comes to recommended treatments. Finally, RNA interference technology has enabled the synthesis of a new antihypertensive treatment administered every 6 months that inhibits the production of hepatic angiotensinogen with a good effect on blood pressure.
    MeSH term(s) Aged ; Humans ; Hypertension/drug therapy ; Blood Pressure ; Antihypertensive Agents/therapeutic use ; Hospitals ; Technology
    Chemical Substances Antihypertensive Agents
    Language French
    Publishing date 2024-02-01
    Publishing country Switzerland
    Document type English Abstract ; Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2024.20.859.252
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Effet des saisons sur la pression artérielle.

    Roth, Léa / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2021  Volume 17, Issue 750, Page(s) 1562–1566

    Abstract: Blood pressure (BP) variability appears to be a cardiovascular risk factor in its own right. Seasonal and temperature changes contribute to BP variations in the medium term with increased BP values in winter and lowered values in summer, and in the short ...

    Title translation Effect of seasons on blood pressure.
    Abstract Blood pressure (BP) variability appears to be a cardiovascular risk factor in its own right. Seasonal and temperature changes contribute to BP variations in the medium term with increased BP values in winter and lowered values in summer, and in the short term by influencing the circadian rhythm of BP. International societies have not issued specific recommendations on the detection of patients at risk of significant seasonal variations in BP, nor on the possible adaptation of antihypertensive treatments. This is a topical issue in the context of global warming, which will make these seasonal differences more significant in the future. Measuring BP outside the medical setting can be of great help in screening and monitoring these patients.
    MeSH term(s) Antihypertensive Agents/therapeutic use ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Circadian Rhythm ; Humans ; Hypertension/diagnosis ; Hypertension/drug therapy ; Hypertension/epidemiology ; Seasons
    Chemical Substances Antihypertensive Agents
    Language French
    Publishing date 2021-09-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: [No title information]

    Ponte, Belén / Wuerzner, Grégoire / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2022  Volume 18, Issue 795, Page(s) 1687

    Title translation Pression sur les médecins en formation.
    MeSH term(s) Clinical Competence ; Humans ; Physicians
    Language French
    Publishing date 2022-09-14
    Publishing country Switzerland
    Document type Editorial
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2022.18.795.1687
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Hypertension artérielle.

    Wuerzner, Grégoire / Ponte, Belen / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2022  Volume 18, Issue 767, Page(s) 169–172

    Abstract: The past year has been particularly rich in the field of arterial hypertension. Our annual review covers the latest epidemiological studies which show that more than 1.2 billion people have high blood pressure, half of them are unaware of it and that ... ...

    Title translation Hypertension: novelties 2021.
    Abstract The past year has been particularly rich in the field of arterial hypertension. Our annual review covers the latest epidemiological studies which show that more than 1.2 billion people have high blood pressure, half of them are unaware of it and that only a quarter of treated patients reach the recommended targets. The impact of poor adherence in young hypertensive patients on cardiovascular events and the effects of intensive treatment in patients over 60 years of age will be discussed. Finally, the adjustment of anti hypertensive treatment in pregnant women with a history of pre-eclampsia according to hemodynamic parameters measured during pregnancy and the effects of potassium supplementation in table salt on cardiovascular events will be presented.
    MeSH term(s) Aged ; Female ; Humans ; Hypertension/drug therapy ; Hypertension/epidemiology ; Middle Aged ; Pre-Eclampsia ; Pregnancy ; Pregnancy Complications, Cardiovascular
    Language French
    Publishing date 2022-01-18
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    DOI 10.53738/REVMED.2022.18.767.169
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Hyponatrémie et diurétiques thiazidiques.

    Bensabre, Sonia / Zisimopoulou, Sofia / Pechère-Bertschi, Antoinette

    Revue medicale suisse

    2021  Volume 17, Issue 750, Page(s) 1556–1559

    Abstract: Thiazide diuretics (hydrochlorothiazide) and « thiazide-like » (chlorthalidone, indapamide) are widely prescribed due to their effectiveness in the treatment of arterial hypertension. The use of thiazides may be complicated by hyponatremia that is ... ...

    Title translation Hyponatremia and thiazides.
    Abstract Thiazide diuretics (hydrochlorothiazide) and « thiazide-like » (chlorthalidone, indapamide) are widely prescribed due to their effectiveness in the treatment of arterial hypertension. The use of thiazides may be complicated by hyponatremia that is associated with increased morbidity and mortality. The pathophysiology of thiazide-induced hyponatremia is not yet clear. It is currently difficult to predict who will develop thiazide-induced hyponatremia. Genetic predisposition is considered, and several studies are attempting to clarify it in order to identify patients at risk of developing hyponatremia after taking a thiazide. Their reintroduction to a patient who already presented hyponatremia upon thiazide should be avoided.
    MeSH term(s) Antihypertensive Agents/adverse effects ; Chlorthalidone/adverse effects ; Humans ; Hyponatremia/chemically induced ; Indapamide ; Thiazides/adverse effects
    Chemical Substances Antihypertensive Agents ; Thiazides ; Indapamide (F089I0511L) ; Chlorthalidone (Q0MQD1073Q)
    Language French
    Publishing date 2021-09-15
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2177010-4
    ISSN 1660-9379
    ISSN 1660-9379
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top